A Practical Guide to Implementing Clinical Mass Spectrometry Systems
Jan 10 2011 Paperback
Now available as an eBook from Amazon>>
“ ...written from a very practical point of view, covering subject matter that is usually learned through experience and is not discussed in standard texts or regulatory guidelines... a valuable reference book for clinical laboratories.”
Sanjay Garg, University of Auckland, New Zealand, in Bioanalysis
Mass spectrometry is becoming increasingly popular as an analytical tool in clinical laboratories. The aim of this publication is to provide practical guidance for laboratories on the implementation of mass spectrometry into a clinical service where there might be limited expertise in the technique. This guidance is the author’s personal recommendation based on over ten years’ experience of clinical mass spectrometry.
Throughout the text, examples are given to illustrate issues that a clinical laboratory might encounter. While some examples relate to the field of immunosuppressive drug monitoring, the issues are common and relevant to any clinical application. The guidance provided is also applicable to instrumentation made by any manufacturer.
This practical guide covers topics that range from instrument selection and business planning to installation, risk management and validation, and also includes suggestions for future prospects in this developing field.
A concise, easy-to-read guide for clinical scientists who would like to know the best way to set up a mass spectrometry system in their laboratory.
Guidance and anecdotes are the result of the author’s ten years’ experience of clinical mass spectrometry. For the novice and those lacking experience in this area, this type of troubleshooting advice is extremely valuable.
The information provided is applicable to instrumentation from any manufacturer and for any clinical application.
Chapter summaries provide checklists for the main activities that need to be put into action.
Table of Contents
Chapter 1 Introduction
Chapter 2 Why Choose Mass Spectrometry?
Chapter 3 Selection of Instrumentation
Chapter 4 Business Planning
Chapter 5 Installation
Chapter 6 Risk Management
Chapter 7 Methodology and Validation
Chapter 8 Standard Operating Procedures
Chapter 9 Future Prospects
Chapter 10 A Blessing and a Curse?
Neil Leaver is a clinical scientist with over 30 years’ experience in the National Health Service and 20 years’ experience in the measurement of immunosuppressive drugs used in transplantation.
Following on from an idea developed in 1996, his first mass spectrometer was installed in December 1997 as a development platform for new rapid liquid chromatography–mass spectrometry/mass spectrometry (LC–MS/MS) methods for therapeutic drug monitoring of the immunosuppressive drugs cyclosporin and tacrolimus. In April 1999, following extensive validation and risk analysis, the UK’s first seven-day week MS service for these drugs was introduced.
Today the service operates three clinical instruments providing national services to hospitals in the UK and Eire. In addition, the service has a number of research and development programmes: these include new method development and assessing new hardware for suitability for use in clinical diagnostics.
Fuel for Thought - Restek Wins Company of the Year ASTM News - New Standard Helps Meet Need for Hydrocarbon Impurity Testing PEFTEC Preview - Excitement Builds for PEFTEC 2017 - Det...
View all digital editions
Nov 29 2017 Antwerp, Belgium
Nov 29 2017 Hamburg, Germany
Dec 03 2017 Houston, Tx, USA
Dec 04 2017 Riyadh, Saudi Arabia
Dec 05 2017 Basra, Iraq